NR4A1 and breast cancer: We performed a case–control study at the Tata Memorial Hospital (TMH), Mumbai, India, to evaluate the risk of premenopausal and postmenopausal BC in relation to different measures of body fatness (BMI, WC and WHR) stratified on hormone receptor (HR) status in a population which has not been exposed to hormone replacement therapy and has not undergone systematic community screening for BC.